Librela 20 mg Solution for Injection for Dogs – Advanced Monoclonal Antibody Therapy for Osteoarthritis Pain
Librela (bedinvetmab) is a revolutionary prescription-only veterinary medicine specifically developed for the alleviation of pain associated with osteoarthritis (OA) in dogs. Unlike traditional NSAIDs, Librela uses a targeted biological approach with a canine monoclonal antibody that binds to Nerve Growth Factor (NGF), interrupting pain signal transmission and helping restore mobility and quality of life.
Key Features & Benefits
- Monthly subcutaneous injection – Convenient once-a-month dosing under veterinary supervision
- Targeted anti-NGF therapy – Specifically blocks Nerve Growth Factor, a key mediator of chronic joint pain
- Improved mobility & activity – Helps dogs move more comfortably, play, and enjoy daily life
- Different mechanism from NSAIDs – Ideal for multimodal pain management plans
- Weight-specific strength – 20 mg strength is typically suitable for dogs weighing 30.1–40 kg
- Sterile single-use vials – Clear to slightly opalescent solution, free from preservatives
Active Ingredient & Composition
Each 1 ml vial contains:
- Active substance: Bedinvetmab 20 mg (canine monoclonal antibody expressed in CHO cells)
- Excipients: L-histidine, histidine hydrochloride monohydrate, trehalose dihydrate, disodium edetate, L-methionine, poloxamer 188, water for injections
Indications
For the alleviation of pain associated with osteoarthritis in dogs. Librela does not cure osteoarthritis or repair damaged joints, but by reducing pain it can significantly improve comfort, mobility and overall quality of life.
Dosage & Administration
Administered by subcutaneous injection once a month (approximately every 28 days). The recommended dose is 0.5–1.0 mg/kg body weight. For dogs 30.1–40 kg, one full 20 mg vial (1 ml) is typically administered. Exact dosage and administration must be determined and performed by a veterinarian.
Storage
- Store and transport refrigerated between 2 °C and 8 °C
- Do not freeze
- Protect from light
- Keep in the original package
Important Safety Information
Librela is a Prescription Only Medicine (POM-V) and must only be used under veterinary direction. Not for use in dogs under 12 months of age, or in breeding, pregnant or lactating dogs. Do not use in cases of known hypersensitivity to bedinvetmab or any excipient. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid accidental self-injection.
Always follow your veterinarian’s instructions and the product information leaflet. This product requires cold-chain handling and is supplied as 2 × 1 ml single-use vials.